Vorige

A. van Rhenen

Internist-hematoloog

Wetenschappelijk onderzoek

2003- 2007

Promotie-onderzoek: The nature of primitive clonogenic AML cells and the role in emergence of minimal residual disease in AML

Afdeling Hematologie VUmc, Amsterdam

Promotor:  prof.dr. P.C. Huijgens,

Co-promotores: Dr. G.J. Schuurhuis en  Prof.dr. G.J. Ossenkoppele 

 

 

 

Lidmaatschap beroepsorganisaties

 

 

 

Nevenfunctie

Publicaties van dr. A. van Rhenen

  • Van Rhenen A, Feller N, Kelder A, Westra A H, Rombouts E, Zweegman S, van der Pol M A, Waisfisz Q, Ossenkoppele G J, Schuurhuis G J; High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival, Clin Cancer Res 2005;11 6520-6527
  • Van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G; The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells, Blood. 2007 Oct 1;110(7):2659-66
  • Van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ; Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission, Leukemia. 2007 Aug;21(8):1700-7
  • Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ; Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia, Stem Cells. 2008 Dec;26(12):3059-67
  • Terwijn M, Feller N, van Rhenen A, Kelder A, Westra G, Zweegman S, Ossenkoppele G, Schuurhuis GJ; Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML, Eur J Cancer. 2009 Jun;45(9):1692-9
  • Pullens HJ, van Rhenen A, Fijnheer R, Vermeijden JR; A case of colonic mantle cell lymphoma: new insights in a rare disease; Endoscopy. 2009;41 Suppl 2:E235
  • Van Rhenen A, Van de Donk N.W.C.J.; Rapidly progressive neurological deterioration without MRI abnormalities: intravascular lymphoma, Blood 2014